Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 2 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
2
Total Funding
$200.0M
Avg Funding
$100.0M
Cities
2

Export 2 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Waltham, United States
$100.0M
raised

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Cambridge, United States
$100.0M
raised

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 2 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

2 Recently Funded Pharmaceutical Post-IPO Equity Startups (June 2026) | VCBacked